Health
Combined point-of-care nucleic acid and antibody testing increases COVID-19 detection – News-Medical.Net
A Cambridge hospital has piloted the use of combined rapid point-of-care nucleic acid and antibody testing for SARS-CoV-2 infection after researchers at the University of Cambridge showed that this approach was superior to virus detection alone for diagnosing…
Reviewed by Emily Henderson, B.Sc.Sep 2 2020
A Cambridge hospital has piloted the use of combined rapid point-of-care nucleic acid and antibody testing for SARS-CoV-2 infection after researchers at the University of Cambridge showed that this approach was superior to virus detection alone for diagnosing COVID-19 disease.
Point-of-care testing – in other words, testing patients as soon as they arrive at the hospital – is essential for enabling healthcare workers to rapidly diagnose patients and…
-
Noosa News14 hours agoMan dies in Brisbane crash, women and girl rushed to hospital
-
Noosa News20 hours agoChilling new details emerge in terrifying childcare centre incident in Peregian Springs on the Sunshine Coast
-
Business19 hours agoAre BHP shares are buy after its results?
-
General23 hours agoProductivity summit ends day two with progress on rules changes to boost housing supply